BRISTOL-MYERS SQUIBB CO (BMY) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:BMY • US1101221083
60.86 USD
+0.09 (+0.15%)
At close: Feb 10, 2026
60.51 USD
-0.35 (-0.58%)
After Hours: 2/10/2026, 8:04:00 PM
BMY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. BMY has an excellent profitability rating, but there are some minor concerns on its financial health. BMY is valued quite cheap, but it does not seem to be growing. Finally BMY also has an excellent dividend rating. These ratings would make BMY suitable for value and dividend investing!
1. Profitability
1.1 Basic Checks
- In the past year BMY was profitable.
- In the past year BMY had a positive cash flow from operations.
- BMY had positive earnings in 4 of the past 5 years.
- Of the past 5 years BMY 4 years had a positive operating cash flow.
1.2 Ratios
- BMY's Return On Assets of 6.23% is amongst the best of the industry. BMY outperforms 86.91% of its industry peers.
- Looking at the Return On Equity, with a value of 32.55%, BMY belongs to the top of the industry, outperforming 94.76% of the companies in the same industry.
- BMY has a better Return On Invested Capital (17.64%) than 95.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.64% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BMY has a Profit Margin of 12.57%. This is amongst the best in the industry. BMY outperforms 84.82% of its industry peers.
- BMY's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 33.51%, BMY belongs to the top of the industry, outperforming 95.29% of the companies in the same industry.
- In the last couple of years the Operating Margin of BMY has grown nicely.
- BMY's Gross Margin of 73.15% is amongst the best of the industry. BMY outperforms 80.63% of its industry peers.
- In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. Health
2.1 Basic Checks
- BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- There is no outstanding debt for BMY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- BMY has an Altman-Z score of 2.33. This is not the best score and indicates that BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of BMY (2.33) is better than 63.35% of its industry peers.
- The Debt to FCF ratio of BMY is 3.20, which is a good value as it means it would take BMY, 3.20 years of fcf income to pay off all of its debts.
- BMY has a better Debt to FCF ratio (3.20) than 88.48% of its industry peers.
- BMY has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 2.41, BMY is doing worse than 79.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.33 |
ROIC/WACC2
WACC8.81%
2.3 Liquidity
- BMY has a Current Ratio of 1.27. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- BMY has a worse Current ratio (1.27) than 77.49% of its industry peers.
- A Quick Ratio of 1.17 indicates that BMY should not have too much problems paying its short term obligations.
- BMY has a Quick ratio of 1.17. This is in the lower half of the industry: BMY underperforms 75.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- BMY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.92% yearly.
- The Revenue has decreased by -0.22% in the past year.
- BMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- The Earnings Per Share is expected to decrease by -3.16% on average over the next years.
- BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.36% yearly.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-3.16%
Revenue Next Year-7.97%
Revenue Next 2Y-5.07%
Revenue Next 3Y-5.93%
Revenue Next 5Y-5.36%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 9.90, the valuation of BMY can be described as very reasonable.
- BMY's Price/Earnings ratio is rather cheap when compared to the industry. BMY is cheaper than 91.62% of the companies in the same industry.
- BMY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.03.
- Based on the Price/Forward Earnings ratio of 10.00, the valuation of BMY can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 88.48% of the companies listed in the same industry.
- BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.97, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 10 |
4.2 Price Multiples
- BMY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BMY is cheaper than 93.19% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, BMY is valued cheaply inside the industry as 94.24% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.1 | ||
| EV/EBITDA | 7.38 |
4.3 Compensation for Growth
- The excellent profitability rating of BMY may justify a higher PE ratio.
- BMY's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 4.07%, BMY is a good candidate for dividend investing.
- BMY's Dividend Yield is rather good when compared to the industry average which is at 0.93. BMY pays more dividend than 96.86% of the companies in the same industry.
- BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.07% |
5.2 History
- On average, the dividend of BMY grows each year by 11.67%, which is quite nice.
- BMY has paid a dividend for at least 10 years, which is a reliable track record.
- BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.67%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- 82.81% of the earnings are spent on dividend by BMY. This is not a sustainable payout ratio.
- The Dividend Rate of BMY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP82.81%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
60.86
+0.09 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners81.87%
Inst Owner Change-2.84%
Ins Owners0.02%
Ins Owner Change-1.11%
Market Cap123.90B
Revenue(TTM)48.19B
Net Income(TTM)6.04B
Analysts70
Price Target58.05 (-4.62%)
Short Float %1.82%
Short Ratio2.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.07% |
Yearly Dividend2.42
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-02 2026-01-02 (0.63)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)5.02%
PT rev (3m)10.23%
EPS NQ rev (1m)-32.94%
EPS NQ rev (3m)-32.35%
EPS NY rev (1m)-8.07%
EPS NY rev (3m)-7.12%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 10 | ||
| P/S | 2.58 | ||
| P/FCF | 8.1 | ||
| P/OCF | 7.45 | ||
| P/B | 6.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.38 |
EPS(TTM)6.15
EY10.11%
EPS(NY)6.09
Fwd EY10%
FCF(TTM)7.52
FCFY12.35%
OCF(TTM)8.16
OCFY13.42%
SpS23.6
BVpS9.11
TBVpS-11.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 17.64% | ||
| ROICexc | 23.19% | ||
| ROICexgc | 118.19% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.33 |
F-Score6
WACC8.81%
ROIC/WACC2
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-3.16%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-7.97%
Revenue Next 2Y-5.07%
Revenue Next 3Y-5.93%
Revenue Next 5Y-5.36%
EBIT growth 1Y44.7%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year13.96%
EBIT Next 3Y0.03%
EBIT Next 5Y-1.68%
FCF growth 1Y10.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.78%
OCF growth 3YN/A
OCF growth 5YN/A
BRISTOL-MYERS SQUIBB CO / BMY FAQ
What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BMY.
What is the valuation status for BMY stock?
ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.
What is the profitability of BMY stock?
BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 8 / 10.
Can you provide the financial health for BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (BMY) is 5 / 10.
What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BMY) stock?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to decline by -1.05% in the next year.